HEMOGENYX PHARMACEUTICALS PLC O吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
19 0 公告 Pediatric Amendment to Clinical Protocol HEMOGENYX PHARMA资讯 05-14 14:19
19 0 公告 AGM Correction HEMOGENYX PHARMA资讯 05-13 14:15
25 0 公告 Placing to Raise £451,250 and Director’s Dealing HEMOGENYX PHARMA资讯 05-08 14:20
54 0 公告 Notice of AGM HEMOGENYX PHARMA资讯 05-02 23:26
32 0 公告 Second Patient Treated with HG-CT-1 CAR-T Therapy HEMOGENYX PHARMA资讯 05-02 14:14
25 0 公告 Final Results HEMOGENYX PHARMA资讯 04-28 14:14
26 0 公告 FDA Annual Report HEMOGENYX PHARMA资讯 04-03 15:10
26 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 03-31 14:22
18 0 公告 First Patient Safety HEMOGENYX PHARMA资讯 03-24 15:17
22 0 公告 Recruitment of Second Patient for Clinical Trials HEMOGENYX PHARMA资讯 03-17 15:20
25 0 公告 Conversion of convertible loan notes HEMOGENYX PHARMA资讯 03-13 23:13
23 0 公告 Institutional investment HEMOGENYX PHARMA资讯 03-11 15:25
23 0 公告 First-in-Human Treatment with HG-CT-1 HEMOGENYX PHARMA资讯 02-24 15:18
37 0 公告 Issue of convertible loan notes HEMOGENYX PHARMA资讯 02-20 00:54
48 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 01-31 17:38
37 0 公告 Placing to raise £340,000 HEMOGENYX PHARMA资讯 01-08 15:12
51 0 公告 Change of Company Secretary and Registered Office HEMOGENYX PHARMA资讯 01-02 15:18
36 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 12-31 15:09
57 0 公告 Opening of First Clinical Site HEMOGENYX PHARMA资讯 12-30 15:09
66 0 公告 Ultrafast CAR-T Manufacturing HEMOGENYX PHARMA资讯 12-19 15:16
56 0 公告 Admission of New Ordinary Shares and New ISIN HEMOGENYX PHARMA资讯 12-11 00:13
55 0 公告 Result of Extraordinary General Meeting HEMOGENYX PHARMA资讯 12-09 21:33
49 0 公告 Site Initiation Visit Completed HEMOGENYX PHARMA资讯 12-09 15:09
54 0 公告 CBR Macrophage Delivery Update HEMOGENYX PHARMA资讯 12-06 15:12
58 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 11-29 15:14
56 0 公告 Notice of Extraordinary General Meeting HEMOGENYX PHARMA资讯 11-22 20:51
50 0 公告 IRB Approval for Phase I Clinical Trial HEMOGENYX PHARMA资讯 11-22 15:16
66 0 公告 Institutional Investment HEMOGENYX PHARMA资讯 11-11 15:15
59 0 公告 Schedule for Phase I Clinical Trial Opening HEMOGENYX PHARMA资讯 10-30 15:16
66 0 公告 Strategic Investment from Prevail Partners, LLC HEMOGENYX PHARMA资讯 10-02 18:21
58 0 公告 Half-year Report HEMOGENYX PHARMA资讯 09-27 14:16
57 0 公告 FLT3 Assay Ready for Phase I Trials at MD Anderson HEMOGENYX PHARMA资讯 09-09 14:16
43 0 公告 CDX Development Update HEMOGENYX PHARMA资讯 09-02 14:16
48 0 公告 Presentation at CBD S&T Conference HEMOGENYX PHARMA资讯 08-28 15:07
48 0 公告 Macrophage-Directed Therapies Summit Presentation HEMOGENYX PHARMA资讯 07-29 14:08
65 0 公告 Result of Annual General Meeting HEMOGENYX PHARMA资讯 06-28 00:48
67 0 公告 Operations Update HEMOGENYX PHARMA资讯 06-17 15:10
53 0 公告 Posting of Annual Report & Notice of AGM HEMOGENYX PHARMA资讯 06-03 15:09
44 0 公告 Final Results HEMOGENYX PHARMA资讯 04-25 15:08
50 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 03-28 16:04
70 0 公告 Placing to Raise US$4.2 million HEMOGENYX PHARMA资讯 02-29 16:09
89 0 公告 CBR Brain Delivery HEMOGENYX PHARMA资讯 02-16 16:08
72 0 公告 CBR Intranasal Delivery HEMOGENYX PHARMA资讯 02-14 16:08
88 0 公告 FDA Consents to Phase I Trials of HEMO-CAR-T HEMOGENYX PHARMA资讯 02-09 16:09
63 0 公告 Approval and Issuance of U.S. Conditioning Patent HEMOGENYX PHARMA资讯 02-02 16:09
65 0 公告 Submission of Complete Response to Clinical Hold HEMOGENYX PHARMA资讯 01-16 16:10
71 0 公告 HEMO-CAR-T Process Qualification Run Completed HEMOGENYX PHARMA资讯 01-08 16:09
63 0 公告 Placing to Raise £534,375 HEMOGENYX PHARMA资讯 11-28 21:27
65 0 公告 CBR Expanded to Treatment of Cancer HEMOGENYX PHARMA资讯 11-27 16:08
62 0 公告 Lentivirus Re-manufacturing Completed HEMOGENYX PHARMA资讯 11-15 16:10
67 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 10-31 16:10
76 0 公告 Half-year Report HEMOGENYX PHARMA资讯 09-28 20:39
62 0 公告 Strategic Investment from Prevail Partners, LLC HEMOGENYX PHARMA资讯 09-18 15:48
70 0 公告 Clinical Hold Lift Plan is accepted by FDA HEMOGENYX PHARMA资讯 09-14 15:11
75 0 公告 CBR Patent Application Update HEMOGENYX PHARMA资讯 09-09 00:22
94 0 公告 Full FDA Review for HEMO-CAR-T IND HEMOGENYX PHARMA资讯 07-10 15:05
80 0 公告 Result of Annual General Meeting HEMOGENYX PHARMA资讯 07-01 00:13
103 0 公告 Posting of Annual Report & Notice of AGM HEMOGENYX PHARMA资讯 06-02 22:24
110 0 公告 Clinical Hold on IND for HEMO-CAR-T HEMOGENYX PHARMA资讯 06-02 19:38
93 0 公告 Submission of IND for HEMO-CAR-T HEMOGENYX PHARMA资讯 05-09 15:09
121 0 公告 Equity Incentive Pool Increase and Option Grant HEMOGENYX PHARMA资讯 04-28 18:19
97 0 公告 Final Results for the Year Ended 31 December 2022 HEMOGENYX PHARMA资讯 04-28 15:04
117 0 公告 HEMO-CAR-T Analytical Release Tests Completed HEMOGENYX PHARMA资讯 03-23 21:50
160 0 公告 Total Voting Rights HEMOGENYX PHARMA资讯 02-28 16:20
193 0 公告 Admission of Shares to Official List HEMOGENYX PHARMA资讯 02-07 23:49
291 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-26 18:26
353 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-26 18:11
379 0 公告 Placing to Raise £4,056,250 HEMOGENYX PHARMA资讯 01-26 16:19
396 0 公告 HEMO-CAR-T 3rd Process Qualification Run Completed HEMOGENYX PHARMA资讯 01-23 15:05
219 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-17 01:53
200 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-17 01:51
181 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-13 20:08
203 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-13 20:08
196 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-13 01:52
176 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-13 01:50
118 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-12 23:08
127 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-12 23:06
164 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-11 01:45
123 0 公告 Second Price Monitoring Extn HEMOGENYX PHARMA资讯 01-09 18:15
114 0 公告 Price Monitoring Extension HEMOGENYX PHARMA资讯 01-09 18:09
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500